ArticleCase reports in oncology

Abemaciclib in Patients with End-Stage Renal Disease and Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Report of 2 Cases.

Vittorio GebbiaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.